In view of increasing epidemic danger potential of some natural plague foci and performing measures to provide specific prevention of this infection, it becomes necessary to carefully monitor the state of immunity in vaccinated (revaccinated) individuals. The aim of the study was to assess humoral and cellular immunity levels in the persons after repeated anti-plague revaccination performed for appropriate epidemiological indications. Evaluation of immune responses to anti-plague revaccination was carried out according to studies of blood samples from 20 people aged 24 to 53 years living in the Caspian sandy natural plague focus located at the territory in Kalmykia Republic. Specific antibody titers to the F1 antigen of plague microbe were ...
Relevance. Despite significant advances in modern medicine in the treatment of infectious diseases, ...
The essential index of functional activity of innate immunity cells in inflammatory reactions, induc...
International audienceImmunization with the live-attenuated Yersinia pseudotuberculosis VTnF1 strain...
Relevance. In 2005 International Health Regulations, the plague, is on the list of dangerous infecti...
Background. Plague is a dangerous natural-focal bacterial disease that can cause emergencies of inte...
At present, the search for biomarkers, which indicate the presence of tense antiplague immunity, is ...
Aim. To compare by flow cytometry the cellular immune status indicators in persons, living on the te...
Some data of the complex immune status study of humans vaccinated with live plague vaccine EV are re...
Relevance. In Russia, the live plague vaccine (LPV) is used for specific prophylaxis of plague. Immu...
Plague is one of the most dangerous diseases and is caused by Yersinia pestis. Effective vaccine dev...
The aim was to carry out a comparative analysis of the immunogenic activity of the live plague vacci...
BackgroundIn Kazakhstan, a live plague vaccine EV 76 NIIEG has been used for plague prophylaxis sinc...
Research objective – studying of a possibility of application antigen – stimulated cellular in vitro...
AbstractLive plague vaccines have saved thousands of human lives in the 20th century and have contin...
International audienceBackground. Plague, a fatal disease caused by the bacillus, Yersinia pestis , ...
Relevance. Despite significant advances in modern medicine in the treatment of infectious diseases, ...
The essential index of functional activity of innate immunity cells in inflammatory reactions, induc...
International audienceImmunization with the live-attenuated Yersinia pseudotuberculosis VTnF1 strain...
Relevance. In 2005 International Health Regulations, the plague, is on the list of dangerous infecti...
Background. Plague is a dangerous natural-focal bacterial disease that can cause emergencies of inte...
At present, the search for biomarkers, which indicate the presence of tense antiplague immunity, is ...
Aim. To compare by flow cytometry the cellular immune status indicators in persons, living on the te...
Some data of the complex immune status study of humans vaccinated with live plague vaccine EV are re...
Relevance. In Russia, the live plague vaccine (LPV) is used for specific prophylaxis of plague. Immu...
Plague is one of the most dangerous diseases and is caused by Yersinia pestis. Effective vaccine dev...
The aim was to carry out a comparative analysis of the immunogenic activity of the live plague vacci...
BackgroundIn Kazakhstan, a live plague vaccine EV 76 NIIEG has been used for plague prophylaxis sinc...
Research objective – studying of a possibility of application antigen – stimulated cellular in vitro...
AbstractLive plague vaccines have saved thousands of human lives in the 20th century and have contin...
International audienceBackground. Plague, a fatal disease caused by the bacillus, Yersinia pestis , ...
Relevance. Despite significant advances in modern medicine in the treatment of infectious diseases, ...
The essential index of functional activity of innate immunity cells in inflammatory reactions, induc...
International audienceImmunization with the live-attenuated Yersinia pseudotuberculosis VTnF1 strain...